Fighting Pharma’s High Prices

Big drug companies keep raising their prices and continue to charge Americans more for their prescriptions than they…

New Research: Big Pharma’s Abuse of the US Patent System Costs Patients Billions Each Year

Pharma-constructed patent thickets on a single drug can cost consumers up to $7.6 billion in one year; Policy…

NEW REPORT: REBATES DO NOT RESULT IN HIGHER DRUG PRICES

Big Pharma, limited competition continue to drive prescription prices higher for patients Washington, D.C., March 1, 2022 –…

The Coalition for Affordable Prescription Drugs (CAPD) represents a diverse group of public and private employers, retirees, unions and the pharmacy benefit managers (PBMs) they partner with to provide affordable, sustainable prescription drug coverage to their employees and members.

Latest Updates

New Polling Shows Strong Majority of Americans Hold Drug Companies Most Responsible for High Drug Prices, Want Congress to Take Action

CAPD Statement on the Delay of the Effective Date of the Rebate Rule

Tweets by RxDrugCoalition

Fast Facts

CAPD
Policy

A common-sense policy agenda to lower drug prices

PBM
Value

Why employers partner with PBMs to effectively manage their prescription drug benefits

CAPD in the states

Information on CAPD’s activity in Florida, Illinois, Nevada, Oklahoma, New York, Pennsylvania, Georgia and Texas